Empagliflozin in adults hospitalised with COVID-19: a (null) hypothesis for RECOVERY
- Resource Type
- Discussion
- Source
- In
The Lancet Diabetes & Endocrinology December 2023 11(12):880-881 - Subject
Analysis and Interpretation Comment - Language
- ISSN
- 2213-8587